Commentary & Deal Flow

LimaCorporate SpA (LIMACO) EUR295m 144A/Reg S sr sec FRN due 2028 (5y). NC1 (MWC B+50bp) (101,par). Equity claw: 1y 40%. B3/(expect B-) (negative, stable expected post transaction/stable). Via CS/GS (B&D) jt glocos/IMI/Mizuho/UniCredit jt books. No reg rights. List Lux. NY law. 

IPT: E+575-600bp coupon at 92-93 OID.

Small group meetings started 01/17 (Investor call at 2:30pm UKT 01/17). UOP: along with EUR12.5m draw on a new EUR65m revolver, EUR7m cash on hand and EUR48.1m equity contribution, to repay and cancel existing EUR60m revolver (EUR54m drawn), redeem its EUR275 sr sec notes due 08/15/23 (callable at 100). Equity sponsor: EQT. Biz: manufacturer and provider of orthopedic implants and enabling technologies for extremities, knee and hip joint replacements. HQ: Udine, Italy.